Estrogens cause rapid activation of IP3-PKC-α signal transduction pathway in HEPG2 cells

被引:87
作者
Marino, M [1 ]
Pallottini, V [1 ]
Trentalance, A [1 ]
机构
[1] Univ Roma 3, Dept Biol, I-00146 Roma, Italy
关键词
D O I
10.1006/bbrc.1998.8413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms through which steroids affect target cells are not fully understood. In addition to the classic model, there is now increasing evidence that steroids can exert rapid actions. It must still be elucidated if rapid and slow estrogen actions produce cooperative and/or integrative functions. The effects of estrogen on inositol trisphosphate (IP3) production and PKC-alpha levels on membrane in the HEPG2 cell line have been investigated. Results show that estrogen addition to HEPG2 cells causes a rapid increase of IP3 production. The effect was totally inhibited by pre-incubation with tyrosine-kinase inhibitor genisteine and with the anti estrogen ICI 182,780, An increased PKC-alpha level on the membrane fraction was present 30 min after estrogen exposure. The strong signal could elicit a variety of cellular responses such as modulation of ion channel, stimulation of cell proliferation, and phosphorylation of cytosolic ER. The ability of estrogen to trigger IP3 production in human hepatoma cells is a novel aspect of estrogen action that requires the current model of hormone stimulation target cells to be revised. (C) 1998 Academic Press.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 24 条
[11]  
LI JJ, 1992, HORMONAL CARCINOGENESIS, P217
[12]  
LOWRY OH, 1951, J BIOL CHEM, V264, P10667
[13]   SIGNAL TRANSDUCTION DURING LIVER-REGENERATION - ROLE OF INSULIN AND VASOPRESSIN [J].
MARINO, M ;
MANGIANTINI, MT ;
SPAGNUOLO, S ;
LULY, P ;
LEONI, S .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 152 (02) :403-409
[14]   MITOGENESIS IN RESPONSE TO PDGF AND BOMBESIN ABOLISHED BY MICROINJECTION OF ANTIBODY TO PIP2 [J].
MATUOKA, K ;
FUKAMI, K ;
NAKANISHI, O ;
KAWAI, S ;
TAKENAWA, T .
SCIENCE, 1988, 239 (4840) :640-643
[15]   Tyrosine kinase/p21(ras)/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells [J].
Migliaccio, A ;
DiDomenico, M ;
Castoria, G ;
deFalco, A ;
Bontempo, P ;
Nola, E ;
Auricchio, F .
EMBO JOURNAL, 1996, 15 (06) :1292-1300
[16]   A NEW, NONGENOMIC ESTROGEN ACTION - THE RAPID RELEASE OF INTRACELLULAR CALCIUM [J].
MORLEY, P ;
WHITFIELD, JF ;
VANDERHYDEN, BC ;
TSANG, BK ;
SCHWARTZ, JL .
ENDOCRINOLOGY, 1992, 131 (03) :1305-1312
[17]   ORAL-CONTRACEPTIVE USE AND LIVER-CANCER [J].
PALMER, JR ;
ROSENBERG, L ;
KAUFMAN, DW ;
WARSHAUER, ME ;
STOLLEY, P ;
SHAPIRO, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (05) :878-882
[18]   MEMBRANE ESTROGEN-RECEPTORS IDENTIFIED BY MULTIPLE ANTIBODY LABELING AND IMPEDED-LIGAND BINDING [J].
PAPPAS, TC ;
GAMETCHU, B ;
WATSON, CS .
FASEB JOURNAL, 1995, 9 (05) :404-410
[19]  
Pink JJ, 1996, CANCER RES, V56, P2321
[20]   Oestrogen receptor activation in the absence of ligand [J].
Smith, CL ;
Conneely, OM ;
OMalley, BW .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) :935-939